Get started
Author

Paolo Rigano

Observed names: P Rigano, P. Rigano, Rigano P
ORCID: 0000-0002-0116-618X
Observed ORCID: 0000-0002-0116-618X
OpenAlex ID: A5030315875
Improving survival with deferiprone treatment in patients with thalassemia major: A prospective multicenter randomised clinical trial under the auspices of the Italian Society for Thalassemia and Hemoglobinopathies
2009 · Aurelio Maggio, Angela Vitrano, et al. · Blood Cells Molecules and Diseases · 96
Long‐term sequential deferiprone–deferoxamine versus deferiprone alone for thalassaemia major patients: a randomized clinical trial
2009 · Aurelio Maggio, Angela Vitrano, et al. · British Journal of Haematology · 71
Real-life experience with hydroxyurea in sickle cell disease: A multicenter study in a cohort of patients with heterogeneous descent
2017 · Paolo Rigano, Lucia De Franceschi, et al. · Blood Cells Molecules and Diseases · 61
Hepatocellular carcinoma in patients with thalassaemia syndromes: clinical characteristics and outcome in a long term single centre experience
2010 · Gaetano Restivo Pantalone, Disma Renda, et al. · British Journal of Haematology · 58
PDF
Current challenges in the management of patients with sickle cell disease – A report of the Italian experience
2019 · Giovanna Russo, Lucia De Franceschi, et al. · Orphanet Journal of Rare Diseases · 53
PDF
Treatment of hepatitis C virus infection with direct‐acting antiviral drugs is safe and effective in patients with hemoglobinopathies
2017 · Raffaella Origa, Maria Laura Ponti, et al. · American Journal of Hematology · 50
Neridronate improves bone mineral density and reduces back pain in β‐thalassaemia patients with osteoporosis: results from a phase 2, randomized, parallel‐arm, open‐label study
2012 · Gian Luca Forni, Silverio Perrotta, et al. · British Journal of Haematology · 45
PDF
Desensitization to hydroxycarbamide following long‐term treatment of thalassaemia intermedia as observed in vivo and in primary erythroid cultures from treated patients
2010 · Paolo Rigano, Alice Pecoraro, et al. · British Journal of Haematology · 44
PDF
Efficacy of Rapamycin as Inducer of Hb F in Primary Erythroid Cultures from Sickle Cell Disease and β -Thalassemia Patients
2015 · Alice Pecoraro, Antonio Troia, et al. · Hemoglobin · 39
Age at diagnosis as an indicator of eligibility for BRCA1 DNA testing in familial breast cancer
1995 · Antonino Giambona, Pina Lo Gioco, et al. · Human Genetics · 39
Hydroxyurea prescription, availability and use for children with sickle cell disease in Italy: Results of a National Multicenter survey
2017 · Raffaella Colombatti, Giovanni Palazzi, et al. · Pediatric Blood & Cancer · 38
Access to emergency departments for acute events and identification of sickle cell disease in refugees
2019 · Lucia De Franceschi, Caterina Lux, et al. · Blood · 35
Long‐term use of deferiprone significantly enhances left‐ventricular ejection function in thalassemia major patients
2012 · Aurelio Maggio, Angela Vitrano, et al. · American Journal of Hematology · 35
PDF
Potential Myocardial Iron Content Evaluation by Magnetic Resonance Imaging in Thalassemia Major Patients Treated with Deferoxamine or Deferiprone During a Randomized Multicenter Prospective Clinical Study
2003 · Massimo Galia, Massimo Midiri, et al. · Hemoglobin · 33
Hepatocellular carcinoma on cirrhosis-free liver in a HCV-infected thalassemic
2005 · Andrea Mancuso, Paolo Rigano, et al. · American Journal of Hematology · 32
Long-term treatment with deferiprone enhances left ventricular ejection function when compared to deferoxamine in patients with thalassemia major
2013 · Aldo Filosa, Angela Vitrano, et al. · Blood Cells Molecules and Diseases · 31
Treatment with hydroxycarbamide for intermedia thalassaemia: decrease of efficacy in some patients during long‐term follow up
2006 · Andrea Mancuso, Aurelio Maggio, et al. · British Journal of Haematology · 31
PDF
Clinical and Hematological Response to Hydroxyurea in a Patient with Hb Leporbp-Thalassemia
1997 · P. Rigano, L. Manfré, et al. · Hemoglobin · 29
Cerebrovascular events in sickle cell‐beta thalassemia treated with hydroxyurea: A single center prospective survey in adult Italians
2013 · Paolo Rigano, Alice Pecoraro, et al. · American Journal of Hematology · 23
PDF
HEPATIC SICKLING: An Unusual Cause of Liver Allograft Dysfunction
1999 · Jan P. Lerut, Nicolas Claeys, et al. · Transplantation · 23
Development of interactive algorithm for clinical management of acute events related to sickle cell disease in emergency department
2014 · Gian Luca Forni, Gabriele Finco, et al. · Orphanet Journal of Rare Diseases · 22
PDF
CLINICAL AND HEMATOLOGICAL RESPONSES TO HYDROXYUREA IN SICILIAN PATIENTS WITH Hb S/β-THALASSEMIA
2001 · Paolo Rigano, Griffin P. Rodgers, et al. · Hemoglobin · 22
Electrocardiographic Abnormalities in Thalassemia Patients with Heart Failure
2009 · Luigi Mancuso, Andrea Mancuso, et al. · Cardiovascular & Haematological Disorders - Drug Targets · 21
Deferiprone versus Deferoxamine in Sickle Cell Disease: Results from a 5-year long-term Italian multi-center randomized clinical trial
2014 · Giusi Calvaruso, Angela Vitrano, et al. · Blood Cells Molecules and Diseases · 20
Sequential Alternating Deferiprone And Deferoxamine Treatment Compared To Deferiprone Monotherapy: Main Findings And Clinical Follow-Up Of A Large Multicenter Randomized Clinical Trial In -Thalassemia Major Patients
2011 · Gaetano Restivo Pantalone, Aurelio Maggio, et al. · Hemoglobin · 20
Works count: 71
Citation count: 1,186
H-index: 22
I10-index: 34
Year
Topic
Type